Patents by Inventor William BOCK
William BOCK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12637414Abstract: The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.Type: GrantFiled: June 3, 2022Date of Patent: May 26, 2026Assignee: Genzyme CorporationInventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Ingrid Mechin, Joseph Kim, Martin Smrcina, Nina Ma, Ronghua Li, Ryan Hartung, William Bock, Bertrand Vivet
-
Patent number: 12630498Abstract: The present disclosure relates to substituted aryl amide compounds, according to Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.Type: GrantFiled: June 3, 2022Date of Patent: May 19, 2026Assignee: Genzyme CorporationInventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Helen Yeoman, Martin Smrcina, Ronghua Li, Ryan Hartung, William Wire, Bertrand Vivet, Nina Ma, William Bock, Aleksandra Weichsel, Andrew Scholte
-
Patent number: 12630521Abstract: The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.Type: GrantFiled: June 3, 2022Date of Patent: May 19, 2026Assignee: Genzyme CorporationInventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Ingrid Mechin, Martin Smrcina, Ronghua Li, Ryan Hartung, William Bock, Bertrand Vivet, Andrew Scholte
-
Patent number: 12613878Abstract: Embodiments of the present invention provide a system for dynamically enabling data connections between large datasets stored in a networked system. The system is configured for allowing users to select at least two datasets from one or more datasets associated with an entity, receiving a selection of a first dataset of the at least two datasets from the users, automatically presenting a set of datasets associated with the first dataset to the users, receiving a selection of a second dataset of the at least two datasets from the set of datasets presented to the users, receiving one or more data connections between at least a first element of the first dataset and at least a second element of the second dataset, and enabling the one or more data connections between at least the first element of the first dataset and at least the second element of the second dataset.Type: GrantFiled: September 3, 2024Date of Patent: April 28, 2026Assignee: BANK OF AMERICA CORPORATIONInventors: John Kling, William Bock, Scott Desmond, Charles Dudley, Jordan Lasher, Sudheer Vajrala, Jason Yeung
-
Publication number: 20260064705Abstract: Embodiments of the present invention provide a system for dynamically enabling data connections between large datasets stored in a networked system. The system is configured for allowing users to select at least two datasets from one or more datasets associated with an entity, receiving a selection of a first dataset of the at least two datasets from the users, automatically presenting a set of datasets associated with the first dataset to the users, receiving a selection of a second dataset of the at least two datasets from the set of datasets presented to the users, receiving one or more data connections between at least a first element of the first dataset and at least a second element of the second dataset, and enabling the one or more data connections between at least the first element of the first dataset and at least the second element of the second dataset.Type: ApplicationFiled: September 3, 2024Publication date: March 5, 2026Applicant: BANK OF AMERICA CORPORATIONInventors: John Kling, William Bock, Scott Desmond, Charles Dudley, Jordan Lasher, Sudheer Vajrala, Jason Yeung
-
Publication number: 20230159439Abstract: The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.Type: ApplicationFiled: June 3, 2022Publication date: May 25, 2023Inventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Ingrid Mechin, Joseph Kim, Martin Smrcina, Nina Ma, Ronghua Li, Ryan Hartung, William Bock, Bertrand Vivet
-
Publication number: 20230147360Abstract: The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.Type: ApplicationFiled: June 3, 2022Publication date: May 11, 2023Inventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Ingrid Mechin, Martin Smrcina, Ronghua Li, Ryan Hartung, William Bock, Bertrand Vivet, Andrew Scholte
-
Patent number: 10437960Abstract: A method, system, computer program product and apparatus related to managing and disseminating information in a health care facility is disclosed. The system may comprise a plurality of input devices, a processor connected to the input devices and a plurality of electronic output devices connected to the processor. The output devices may include a master patient information display, an electronic patient room information display, a master precaution display, a patient hourly rounding display and an individual room precaution display. The method may comprises receiving from at least one input device data associated with a plurality of patients, and displaying for each patient the information, based on the data received, that is associated with each patient, and then updating on each output device the information when it changes.Type: GrantFiled: August 26, 2015Date of Patent: October 8, 2019Assignee: SHELDON INVESTMENT GROUP, INC.Inventors: Daniel Sheldon, Sonne DeVries, Clare Cooke, Dennis Bednar, William Bock, Randall Karlsen, Noel Wolbing, Saad Yusuf
-
Publication number: 20150363556Abstract: A method, system, computer program product and apparatus related to managing and disseminating information in a health care facility is disclosed. The system may comprise a plurality of input devices, a processor connected to the input devices and a plurality of electronic output devices connected to the processor. The output devices may include a master patient information display, an electronic patient room information display, a master precaution display, a patient hourly rounding display and an individual room precaution display. The method may comprises receiving from at least one input device data associated with a plurality of patients, and displaying for each patient the information, based on the data received, that is associated with each patient, and then updating on each output device the information when it changes.Type: ApplicationFiled: August 26, 2015Publication date: December 17, 2015Inventors: Daniel Sheldon, Sonne DeVries, Clare Cooke, Dennis Badnar, William Bock, Randall Karlsen, Noel Wolbing, Saad Yusuf
-
Patent number: 8501981Abstract: The invention relates to compounds of the formula I in which R1, R2, X, A, B, Z and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula I and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.Type: GrantFiled: December 17, 2008Date of Patent: August 6, 2013Assignee: SANOFIInventors: Stephanie Hachtel, Juergen Dedio, Elisabeth DeFossa, Sven Grueneberg, Holger Heitsch, William Bock, Charlie Chen, Raymond Kosley, Chung-Yi Kung, Marcel Patek, Rosy Sher, Stephen Shimshock, Aleksandra Weichsel
-
Publication number: 20120078661Abstract: A method, system, computer program product and apparatus related to managing and disseminating information in a health care facility is disclosed. The system may comprise a plurality of input devices, a processor connected to the input devices and a plurality of electronic output devices connected to the processor. The output devices may include a master patient information display, an electronic patient room information display, a master precaution display, a patient hourly rounding display and an individual room precaution display. The method may comprise receiving from at least one input device data associated with a plurality of patients, and displaying for each patient the information, based on the data received, that is associated with each patient, and then updating on each output device the information when it changes.Type: ApplicationFiled: December 30, 2010Publication date: March 29, 2012Applicant: Scan Am CompanyInventors: Daniel Sheldon, Sonne DeVries, Clare Cooke, Dennis Bednar, William Bock, Randall Karlsen, Noel Wolbing, Saad Yusuf
-
Publication number: 20090227625Abstract: The invention relates to compounds of the formula I in which R1, R2, X, A, B, Z and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula I and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.Type: ApplicationFiled: December 17, 2008Publication date: September 10, 2009Applicant: sanofi-aventisInventors: Stephanie HACHTEL, Juergen DEDIO, Elisabeth DeFOSSA, Sven GRUENEBERG, Holger HEITSCH, William BOCK, Charlie CHEN, Raymond KOSLEY, Chung-Yi KUNG, Marcel PATEK, Rosy SHER, Stephen SHIMSHOCK, Aleksandra WEICHSEL